
Mechanism-guided add-on cannabidiol (CBD) therapy for pediatric epilepsy: Insights from Dravet Syndrome (2026)
Won Chan Oh, PhD
Associate Professor, Department of Pharmacology, University of Colorado Anschutz Medical Campus
Dravet Syndrome (DS) is a severe childhood epilepsy that often resists standard treatments, leaving children at risk of cognitive damage and sudden death. Cannabidiol (CBD) was FDA-approved for DS in 2018, but we still don’t understand how it works in the […]



